Compare ALEMBIC PHARMA with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA NATCO PHARMA ALEMBIC PHARMA/
NATCO PHARMA
 
P/E (TTM) x 29.0 47.1 61.6% View Chart
P/BV x 2.9 3.1 93.0% View Chart
Dividend Yield % 1.8 0.7 247.2%  

Financials

 ALEMBIC PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-21
NATCO PHARMA
Mar-21
ALEMBIC PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,150995 115.6%   
Low Rs527492 107.1%   
Sales per share (Unadj.) Rs274.4112.5 243.8%  
Earnings per share (Unadj.) Rs56.724.3 233.8%  
Cash flow per share (Unadj.) Rs66.030.7 215.3%  
Dividends per share (Unadj.) Rs14.005.25 266.7%  
Avg Dividend yield %1.70.7 236.4%  
Book value per share (Unadj.) Rs260.9225.1 115.9%  
Shares outstanding (eoy) m196.56182.34 107.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.16.6 46.3%   
Avg P/E ratio x14.830.6 48.2%  
P/CF ratio (eoy) x12.724.2 52.4%  
Price / Book Value ratio x3.23.3 97.3%  
Dividend payout %24.721.6 114.1%   
Avg Mkt Cap Rs m164,818135,564 121.6%   
No. of employees `000NANA-   
Total wages/salary Rs m10,5124,149 253.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,93120,521 262.8%  
Other income Rs m8751,060 82.5%   
Total revenues Rs m54,80621,581 254.0%   
Gross profit Rs m14,8016,038 245.1%  
Depreciation Rs m1,8351,169 156.9%   
Interest Rs m160133 120.5%   
Profit before tax Rs m13,6815,796 236.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5331,372 184.6%   
Profit after tax Rs m11,1484,424 252.0%  
Gross profit margin %27.429.4 93.3%  
Effective tax rate %18.523.7 78.2%   
Net profit margin %20.721.6 95.9%  
BALANCE SHEET DATA
Current assets Rs m25,77923,373 110.3%   
Current liabilities Rs m12,8085,256 243.7%   
Net working cap to sales %24.188.3 27.2%  
Current ratio x2.04.4 45.3%  
Inventory Days Days2363 37.5%  
Debtors Days Days273 3.2%  
Net fixed assets Rs m41,31124,546 168.3%   
Share capital Rs m393365 107.7%   
"Free" reserves Rs m50,88340,676 125.1%   
Net worth Rs m51,27641,041 124.9%   
Long term debt Rs m1,9999 22,210.0%   
Total assets Rs m67,09047,919 140.0%  
Interest coverage x86.444.6 193.8%   
Debt to equity ratio x00 17,776.7%  
Sales to assets ratio x0.80.4 187.7%   
Return on assets %16.99.5 177.2%  
Return on equity %21.710.8 201.7%  
Return on capital %26.014.4 179.9%  
Exports to sales %66.80-   
Imports to sales %12.710.9 116.7%   
Exports (fob) Rs m36,020NA-   
Imports (cif) Rs m6,8452,231 306.8%   
Fx inflow Rs m36,02011,194 321.8%   
Fx outflow Rs m6,8452,231 306.8%   
Net fx Rs m29,1758,963 325.5%   
CASH FLOW
From Operations Rs m14,6342,988 489.8%  
From Investments Rs m-8,388-1,033 812.0%  
From Financial Activity Rs m-5,974-1,857 321.7%  
Net Cashflow Rs m26260 437.2%  

Share Holding

Indian Promoters % 69.1 48.8 141.6%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 17.8 28.1 63.2%  
FIIs % 6.0 11.9 50.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 51.2 59.4%  
Shareholders   106,437 85,828 124.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Related Views on News

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 23, 2022 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS